Contents
|
|
|
Reviews
Laboratory
Investigations
Clinical
investigations
Miscellanea
|
|
|
Reviews
|
|
.
|
Vilela RA, Navarro NF, Faria ET, Ferreira EB, Ruzza RZ, Gadia R,
Guerra ENS, Reis PEDD.
Use of stereotactic body radiation
therapy for oligometastatic recurrent prostate cancer: A
systematic review.
J Med Imaging Radiat Oncol. 2018 May
28. doi: 10.1111/1754-9485.12747. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
OLIGOMETASTASES
IN LYMPH NODES
|
|
.
|
Matsushita H, Jingu K, Umezawa R, Yamamoto T, Ishikawa Y,
Takahashi N, Katagiri Y, Kadoya N.
Stereotactic
Radiotherapy for Oligometastases in Lymph Nodes-A Review.
Technol
Cancer Res Treat. 2018 Jan 1;17:1533033818803597. doi:
10.1177/1533033818803597.
Source
| Full
text |
Similar
articles
|
|
|
Laboratory
investigations
|
|
|
|
Clinical
investigations
|
|
.
|
Bowden P, See AW, Frydenberg M, Haxhimolla H, Costello AJ, Moon D,
Ruljancich P, Grummet J, Crosthwaite A, Pranavan G, Peters JS, So
K, Gwini SM, McKenzie DP, Nolan S, Smyth LML, Everitt C.
Fractionated stereotactic body radiotherapy for up to
five prostate cancer oligometastases: Interim outcomes of a
prospective clinical trial.
Int J Cancer. 2019 Jun 14.
doi: 10.1002/ijc.32509. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
|
Nicosia L, Franzese C, Mazzola R, Franceschini D, Rigo M,
D'agostino G, Corradini S, Alongi F, Scorsetti M.
Recurrence
pattern of stereotactic body radiotherapy in oligometastatic
prostate cancer: a multi-institutional analysis.
Strahlenther Onkol. 2019 Sep 26. doi:
10.1007/s00066-019-01523-9. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
BONE
OLIGOMETASTATIC DISEASE
|
|
.
|
Patel PH, Chaw CL, Tree AC, Sharabiani M, van As NJ.
Stereotactic
body radiotherapy for bone oligometastatic disease in prostate
cancer.
World J Urol. 2019 Jul 25. doi:
10.1007/s00345-019-02873-w. [Epub ahead of print]
Source
|
Abstract
| Full
text | Similar
articles
|
|
|
OLIGOMETASTASES
IN LYMPH NODES
|
|
.
|
Loi M, Di Cataldo V, Francolini G, Bonomo P, Masi L, Simontacchi
G, Detti B, Greto D, Desideri I, Livi L.
Single-Fraction
Stereotactic Body Radiotherapy for Oligometastatic Lymph Node
Relapse in Prostate Cancer.
Oncol Res Treat. 2018 Oct
13;41(11). doi: 10.1159/000491605. [Epub ahead of print]
Source
|
Abstract
|
Similar
articles
|
|
|
HORMONE-SENSITIVE
OLIGOMETASTATIC
|
|
.
|
Radwan
N, Phillips R, Ross A, Rowe SP, Gorin MA, Antonarakis ES, Deville
C, Greco S, Denmeade S, Paller C, Song DY, Diehn M, Wang H,
Carducci M, Pienta KJ, Pomper MG, DeWeese TL, Dicker A,
Eisenberger M, Tran PT.
A
phase II randomized trial of Observation versus stereotactic
ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
BMC
Cancer. 2017 Jun 29;17(1):453. doi: 10.1186/s12885-017-3455-6.
Source
|
Full
text |
Similar
articles
|
|
|
HORMONE-RESISTANT
OLIGOMETASTATIC
|
|
.
|
Bravo I.
Comment on 'Efficacy of stereotactic body
radiotherapy in oligorecurrent and in oligoprogressive prostate
cancer: new evidence from a multicentric study'.
Br J
Cancer. 2018 Feb 6;118(3):e1. doi: 10.1038/bjc.2017.342. Epub 2017
Nov 16.
Source
| Full
text |
Similar
articles
Letter
to the Editor referring to:
Triggiani L et al., Efficacy of
stereotactic body radiotherapy in oligorecurrent and in
oligoprogressive prostate cancer: new evidence from a multicentric
study.
Br J Cancer. 2017 Jun 6;116(12):1520-1525. doi:
10.1038/bjc.2017.103. Epub 2017 Apr 27.
Source
/
Full
text
|
|
|
.
|
Triggiani L, Mazzola R,
Magrini SM, Alongi F, Buglione M.
Reply to 'Comment on
'Efficacy of stereotactic body radiotherapy in oligorecurrent and
in oligoprogressive prostate cancer: new evidence from a
multicentric study''.
Br J Cancer. 2018 Feb 6;118(3):e2.
doi: 10.1038/bjc.2017.406. Epub 2017 Nov 16.
Source
| Full
text |
Similar
articles
Letter
to the Editor referring to:
Bravo I, Comment on 'Efficacy of
stereotactic body radiotherapy in oligorecurrent and in
oligoprogressive prostate cancer: new evidence from a multicentric
study'. Br J Cancer. 2018 Feb 6;118(3):e1. doi:
10.1038/bjc.2017.342. Epub 2017 Nov 16. Source
/
Full
text
|
|
|
.
|
Triggiani L, Mazzola R, Magrini SM, Ingrosso G, Borghetti P,
Trippa F, Lancia A, Detti B, Francolini G, Matrone F, Bortolus R,
Fanetti G, Maranzano E, Pasqualetti F, Paiar F, Bonù ML,
Magli A, Bruni A, Mazzeo E, Franzese C, Scorsetti M, Alongi F,
Jereczek-Fossa BA, Ost P, Buglione M.
Metastasis-directed
stereotactic radiotherapy for oligoprogressive
castration-resistant prostate cancer: a multicenter study.
World
J Urol. 2019 Mar 11. doi: 10.1007/s00345-019-02717-7. [Epub ahead
of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Triggiani L, Alongi F,
Buglione M, Detti B, Santoni R, Bruni A, Maranzano E, Lohr F,
D'Angelillo R, Magli A, Bonetta A, Mazzola R, Pasinetti N,
Francolini G, Ingrosso G, Trippa F, Fersino S, Borghetti P,
Ghirardelli P, Magrini SM.
Efficacy of stereotactic body
radiotherapy in oligorecurrent and in oligoprogressive prostate
cancer: new evidence from a multicentric study.
Br J
Cancer. 2017 Jun 6;116(12):1520-1525. doi: 10.1038/bjc.2017.103.
Epub 2017 Apr 27.
Source
| Full
text |
Similar
articles
|
|
|
IMAGING
|
|
|
Marzec J, Becker J, Paulsen F, Wegener D, Olthof SC, Pfannenberg
C, Schwenck J, Bedke J, Stenzl A, Nikolaou K, la Fougère C,
Zips D, Müller AC.
68Ga-PSMA-PET/CT-directed
IGRT/SBRT for oligometastases of recurrent prostate cancer after
initial surgery.
Acta Oncol. 2019 Sep 27:1-8. doi:
10.1080/0284186X.2019.1669816. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Pasqualetti F, Panichi M, Sollini M, Sainato A, Galli L, Morganti
R, Chiacchio S, Marciano A, Zanca R, Mannelli L, Coraggio G,
Sbrana A, Cocuzza P, Montrone S, Baldaccini D, Gonnelli A,
Molinari A, Cantarella M, Mazzotti V, Ricci S, Paiar F, Erba PA.
[18F]Fluorocholine PET/CT-guided
stereotactic body radiotherapy in patients with recurrent
oligometastatic prostate cancer.
Eur J Nucl Med Mol
Imaging. 2019 Oct 16. doi: 10.1007/s00259-019-04482-6. [Epub ahead
of print]
Source
.
Similar
articles
|
|
|
Miscellanea
|
|
|
|
|
|
|
|
